Name: How do you manage patients who develop candidiasis while on IL-17 inhibitors?
Uploaded: 2021-04-22T00:00:00.000Z
Description: How do you manage patients who develop candidiasis while on IL-17 inhibitors?

Welcome to Dermbits! Watch short videos of KOLs answering your questions

thumbnail_dermbits-colorful.png

dermbits-colorful.png

Dermbits

MD, MPH

How do you manage patients who develop candidiasis while on IL-17 inhibitors?

Psoriasis

You. Most patients who present with oral candidiasis while on IL 17 inhibitors will have mild or moderate oral candidiasis. Most cases actually will be mild and those can be managed without discontinuing IL 17 inhibitors. So how do I manage them? When I have a patient who present with oral candidiasis, typically Lee, I use oral fluconazole because it is quicker and just easier to administer. So I use oral fluconosol, either 100 milligrams or 200 milligrams, depending on the person's weight, daily for seven days. Now, I also want to let you know the recommendation by the id societies for them. If the patient presents with more mild to moderate oral candidiasis, they recommend the use of clotrimazole, troches or nystatin suspension topically. For these patients and for the more moderate or severe cases, they also recommend oral fluconazole 100 or 200 milligrams really at a dosing of about three milligrams per kilogram for seven to 14 days. Again, I personally do 100 milligrams or 200 milligrams, depending on patient's weight, daily for seven days, and I find that to be quite effective. But I know that some of my colleagues prefer using topical antifungal agents and I think those have work quite well as well, as long as you use them for about two weeks or so. Bye.

How do you manage patients who develop candidiasis while on IL-17 inhibitors?

Related CME